100 101 102 103 [104] 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 
| PRODUCT NAME | CAS Registry Number | ||||||||
| Mavacamten impurity 19 (1 supplier) | 1642288-97-8 | ||||||||
| Mavacamten impurity 20 (1 supplier) | 1642289-54-0 | ||||||||
| Mavacamten impurity 21 (1 supplier) | 1642289-43-7 | ||||||||
| Mavacamten impurity 22 (1 supplier) | 1642289-38-0 | ||||||||
| Mavacamten impurity 23 (2 suppliers) | 1642289-11-9 | ||||||||
| Mavacamten impurity 24 (1 supplier) | 1642289-74-4 | ||||||||
| Mavacamten impurity 25 (1 supplier) | 1642289-56-2 | ||||||||
| Mavacamten impurity 26 (1 supplier) | 1642289-29-9 | ||||||||
| Mavacamten impurity 27 (1 supplier) | 1642289-26-6 | ||||||||
| Mavacamten impurity 28 (1 supplier) | 1642289-62-0 | ||||||||
| Mavacamten impurity 29 (1 supplier) | 1642289-04-0 | ||||||||
| Mavacamten impurity 30 (1 supplier) | 1642288-69-4 | ||||||||
| Mavacamten impurity 31 (1 supplier) | 1642288-74-1 | ||||||||
| Mavacamten impurity 32 (1 supplier) | 1642288-66-1 | ||||||||
| Mavacamten impurity 33 (1 supplier) | 1642288-65-0 | ||||||||
| Mavacamten impurity 34 (1 supplier) | 1642288-60-5 | ||||||||
| Mavacamten impurity 35 (1 supplier) | 1642289-94-8 | ||||||||
| Mavacamten impurity 36 (1 supplier) | 1642289-61-9 | ||||||||
| Mavacamten impurity 37 (1 supplier) | 1642288-79-6 | ||||||||
| Mavacamten impurity 38 (1 supplier) | 1642288-72-9 | ||||||||
| Mavacamten-d1 (0 suppliers) | 2453251-02-8 | ||||||||
| Mavacamten-d5 (0 suppliers) | 2453251-00-6 | ||||||||
| Mavacamten-d6 (0 suppliers) | 2453251-18-6 | ||||||||
Mavacoxib (8 suppliers)
IUPAC Name: 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide | CAS Registry Number: 170569-88-7Synonyms: Mavacoxib (USAN), UNII-YFT7X7SR77, CHEBI:139437, CID9843089, PHA-739521, D04863, 4-[5-(4-Fluoro-phenyl)-3-trifluoromethyl-pyrazol-1-yl]-benzenesulfonamide, 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
InChIKey: TTZNQDOUNXBMJV-UHFFFAOYSA-N | 170569-88-7 | ||||||||
Mavatrep (6 suppliers)
IUPAC Name: 2-[2-[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-3H-benzimidazol-5-yl]phenyl]propan-2-ol | CAS Registry Number: 956274-94-5Synonyms: UNII-F197218T99, Mavatrep (USAN), Mavatrep [USAN], JNJ-39439335, SCHEMBL1796599, SCHEMBL1797450, CHEMBL2364618, BC600772, HY-16935, F197218T99, D10370, Benzenemethanol, alpha,alpha-dimethyl-2-(2-((1E)-2-(4-(trifluoromethyl)phenyl)ethenyl)-1H-benzimidazol-6-yl)-
InChIKey: ORDHXXHTBUZRCN-NTEUORMPSA-N | 956274-94-5 | ||||||||
Mavelertinib (6 suppliers)
IUPAC Name: N-[(3R,4R)-4-fluoro-1-[6-[(3-methoxy-1-methylpyrazol-4-yl)amino]-9-methylpurin-2-yl]pyrrolidin-3-yl]prop-2-enamide | CAS Registry Number: 1776112-90-3Synonyms: UNII-YXX2180047, YXX2180047, PF-06747775, N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidin-3-yl)acrylamide, Mavelertinib [USAN], SCHEMBL16714537, JYIUNVOCEFIUIU-GHMZBOCLSA-N, AKOS032945529, ZINC231225813, Egfr T790M inhibitor PF-06747775, PF-06747775, >=98% (HPLC), 2-Propenamide, N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)-3-pyrrolidinyl)-, N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol -4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidin-3-yl)acrylamide
InChIKey: JYIUNVOCEFIUIU-GHMZBOCLSA-N | 1776112-90-3 | ||||||||
| MAVILEX (2 suppliers) | 109225-31-2 | ||||||||
| MAVIOQUINONE (3 suppliers) | 11004-53-8 | ||||||||
| Mavodelpar free acid hydrochloride (1 supplier) | |||||||||
Mavoglurant racemate (5 suppliers)
IUPAC Name: methyl (3aR,4S,7aR)-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-3,3a,5,6,7,7a-hexahydro-2H-indole-1-carboxylate | CAS Registry Number: 1636881-61-2Synonyms: Mavoglurant, AFQ056, 543906-09-8, UNII-GT0I9SV4F6, AFQ-056, GT0I9SV4F6, Mavoglurant [USAN:INN], AFQ 056, 4oo9, Mavoglurant, AFQ056, D0G5PF, SCHEMBL989279, GTPL7586, CHEMBL3087515, DTXSID30202777, ZFPZEYHRWGMJCV-ZHALLVOQSA-N, BCP20624, EX-A1564, ZINC3817189, BDBM50443085
InChIKey: ZFPZEYHRWGMJCV-ZHALLVOQSA-N | 1636881-61-2 | ||||||||
| Mavoglurant-[13C,d3] (1 supplier) | 1404073-41-1 | ||||||||
Mavorixafor (8 suppliers)
IUPAC Name: N'-(1H-benzimidazol-2-ylmethyl)-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine | CAS Registry Number: 558447-26-0Synonyms: AMD070, AMD 070, AMD-070, (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine, 690656-53-2, CHEMBL1088913, AMD11070, ST51054666, S14-0353, UNII-0G9LGB5O2W, SureCN2511950, CHEMBL518924, CTK8C0587, QCR-228, CHEBI:608408, N'-(1H-Benzo[d]imidazol-2-ylmethyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine Trihydrobromide Dihydrate, ANW-64931, DCL000040, AMD-070 HCl 75%(w/w%), AKOS016005047
InChIKey: WVLHHLRVNDMIAR-IBGZPJMESA-N | 558447-26-0 | ||||||||
Mavorixafor trihydrochloride (5 suppliers)
IUPAC Name: N'-(1H-benzimidazol-2-ylmethyl)-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine;trihydrochloride | CAS Registry Number: 2309699-17-8Synonyms: Mavorixafor (trihydrochloride), Mavorixafor hydrochloride, (S)-N1-((1H-Benzo[D]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine trihydrochloride, HY-50101A, CS-1111
InChIKey: FTHQTOSCZZCGHB-VLEZWVESSA-N | 2309699-17-8 | ||||||||
| Mavrilimumab (3 suppliers) | 1085337-57-0 | ||||||||
| MAX PROTEIN (3 suppliers) | 136047-18-2 | ||||||||
| MAX Protein, Human, Recombinant (His & GST) (1 supplier) | |||||||||
| MAX Protein, Human, Recombinant (His) (1 supplier) | |||||||||
MAX-40279 (5 suppliers)
IUPAC Name: 7-(4-fluoro-2-methoxyphenyl)-6-methyl-N-(1-piperidin-4-ylpyrazol-4-yl)thieno[3,2-d]pyrimidin-2-amine | CAS Registry Number: 2070931-57-4Synonyms: UNII-DL772G3NN7, DL772G3NN7, CHEMBL4297470, SCHEMBL18410078, EX-A4057, DB15191, 7-(4-Fluoro-2-methoxyphenyl)-6-methyl-N-(1-(piperidin-4-yl)-1H-pyrazol-4-yl) thieno (3,2-d)pyrimidin-2-amine, Thieno(3,2-d)pyrimidin-2-amine, 7-(4-fluoro-2-methoxyphenyl)-6-methyl-N-(1-(4-piperidinyl)-1H-pyrazol-4-yl)-
InChIKey: AVIOBQFPAGEICQ-UHFFFAOYSA-N | 2070931-57-4 | ||||||||
| MAX-40279 hemiadipate (3 suppliers) | 2388506-44-1 | ||||||||
| MAX-40279 hemifumarate (4 suppliers) | 2388506-43-0 | ||||||||
| MAX-40279 hydrochloride (2 suppliers) | 2388506-51-0 | ||||||||
| MAX1 (1 supplier) | 487036-63-5 | ||||||||
| MAX8 (1 supplier) | 944792-75-0 | ||||||||
Maxacalcitol (18 suppliers)
IUPAC Name: (1R,3S,5Z)-5-[(2E)-2-[(1S,3aS,7aS)-1-[(1S)-1-(3-hydroxy-3-methylbutoxy)ethyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | CAS Registry Number: 103909-75-7Synonyms: Prezios, Oxarol, 22-Oxacalcitriol, 22-oxa-calcitriol, Prezios (TN), Oxarol (TN), Maxacalcitol [USAN], Sch 209579, Maxacalcitol (JAN/USAN/INN), 1,25-Dihydroxy-22-oxavitamin D3, 22-Oxa-1,25-dihydroxyvitamin D3, Sch-209579, C26H42O4, MC 1275, 22-Oxa-1,25(OH)2D3, LMST03020060, ZINC04474617, CID6398761, MC-1275, 1alpha,25-Dihydroxy-22-oxavitamin D3
InChIKey: DTXXSJZBSTYZKE-ZDQKKZTESA-N | 103909-75-7 | ||||||||
| MAXADILAN (5 suppliers) | 135374-80-0 | ||||||||
MAXAFIL (2 suppliers)
IUPAC Name: 2-ethoxyethyl (E)-3-(4-methoxyphenyl)prop-2-enoate; (2-methyl-5-propan-2-ylcyclohexyl) 2-aminobenzoate | CAS Registry Number: 78065-42-6Synonyms: Maxafil, 2-Propenoic acid, 3-(4-methoxyphenyl)-, 2-ethoxyethyl ester, mixt. with 2-methyl-5-(1-methylethyl)cyclohexyl 2-aminobenzoate, Cyclohexanol, 2-methyl-5-(1-methylethyl)-, 2-aminobenzoate, mixt. with 2-Ethoxyethyl 3-(4-methoxyphenyl)-2-propenoate
InChIKey: RGEMNJVOIALBCU-RRJFPGPQSA-N | 78065-42-6 | ||||||||
| MAXICHEM P 15MC (2 suppliers) | 28902-37-6 | ||||||||
| MAXICROP (2 suppliers) | 75923-38-5 | ||||||||
| MAXIKDIOL (2 suppliers) | 161161-47-3 | ||||||||
| MAXILON BLUE 3RL (2 suppliers) | 61356-35-2 |